|
37
|
195
|
8dnnA |
Crystal structure of neutralizing antibody 80 in complex with sars-cov-2 receptor binding domain |
|
46
|
227
|
8dnnB |
Crystal structure of neutralizing antibody 80 in complex with sars-cov-2 receptor binding domain |
|
51
|
216
|
8faxB |
Fab 1249a8-mers stem helix complex |
|
49
|
221
|
8faxA |
Fab 1249a8-mers stem helix complex |
|
3
|
12
|
8faxL |
Fab 1249a8-mers stem helix complex |
|
37
|
196
|
7yowC |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
|
41
|
216
|
7yowB |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
|
40
|
215
|
7yowA |
Crystal structure of sars-cov-2 omicron variant spike receptor-binding domain (rbd) in complex with ncv2sg48 fab |
|
11
|
108
|
8d21F |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
|
44
|
323
|
8d21A |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
|
50
|
173
|
8d21B |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
|
18
|
123
|
8d21E |
Cryo-em structure of the vrc321 clinical trial, vaccine-elicited, human antibody 1b06 in complex with a stabilized nc99 ha trimer |
|
72
|
275
|
8gomA |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
|
16
|
119
|
7wp8E |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
15
|
118
|
7wp8H |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
13
|
100
|
8gomB |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
|
39
|
192
|
8gonD |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
|
52
|
244
|
8gomE |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
|
55
|
245
|
8gonE |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
|
76
|
275
|
8gonA |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
|
0
|
9
|
8gomC |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
|
17
|
118
|
7wp8D |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
11
|
113
|
7wp8G |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
10
|
104
|
7wp8C |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
15
|
183
|
7wp8F |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
15
|
106
|
7wp8L |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk1628x in complex with three neutralizing antibodies |
|
15
|
100
|
8gonB |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-t1006i-hla-a2 |
|
35
|
193
|
8gomD |
Sars-cov-2 specific private tcr rlq7 in complex with rlq-hla-a2 |
|
16
|
119
|
7wp6B |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
15
|
118
|
7wp6H |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
12
|
113
|
7wp6I |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
18
|
183
|
7wp6F |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
10
|
104
|
7wp6C |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
14
|
118
|
7wp6D |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
13
|
106
|
7wp6L |
Cryo-em structure of sars-cov-2 recombinant spike protein stfk in complex with three neutralizing antibodies |
|
23
|
115
|
7tn9G |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
13
|
110
|
7tn9V |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
20
|
103
|
7tn9N |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
22
|
116
|
7tn9A |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
25
|
113
|
7tn9B |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
50
|
261
|
7tn9S |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
22
|
115
|
7tn9M |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
15
|
107
|
7tn9H |
Structure of the inmazeb cocktail and resistance to escape against ebola virus |
|
46
|
231
|
8fbwA |
Crystal structure of siv-1 v2 antibody nci05 in complex with a v2 peptide |
|
46
|
214
|
8fbwB |
Crystal structure of siv-1 v2 antibody nci05 in complex with a v2 peptide |
|
3
|
16
|
8fbwE |
Crystal structure of siv-1 v2 antibody nci05 in complex with a v2 peptide |
|
38
|
214
|
7wh8A |
Sars-cov-2 spike in complex with the zb8 neutralizing antibody fab (focused refinement on fab-rbd) |
|
36
|
224
|
7wh8B |
Sars-cov-2 spike in complex with the zb8 neutralizing antibody fab (focused refinement on fab-rbd) |
|
34
|
277
|
7wh8C |
Sars-cov-2 spike in complex with the zb8 neutralizing antibody fab (focused refinement on fab-rbd) |
|
48
|
218
|
7uzcF |
Structure of the sars-cov-2 rbd in complex with the mouse antibody fab fragment, m8a-34 |
